Edition:
India

Pharmagest H1 Operating Income Up At 18.7 Million Euros


Friday, 20 Sep 2019 

Sept 20 (Reuters) - PHARMAGEST INTERACTIVE SA ::OUTLOOK FOR GROWTH AND PROFITABILITY CONFIRMED FOR H2 2019..STRONG GROWTH IN ADJUSTED EPS: +19.55%, BOOSTED BY AN EXCEPTIONAL EVENT IN MAY 2019 ( SALE OF INTECUM SHARES TO PHARMATHEK)..H1 OPERATING INCOME EUR 18.7 MILLION VERSUS EUR 17.4 MILLION YEAR AGO.AT 30 JUNE 2019, PHARMAGEST GROUP'S GROSS CASH POSITION INCREASED TO EUR 104.86M, COMPARED TO EUR 95.78M AT 30 JUNE 2018.H1 NET PROFIT EUR 14.6 MILLION VERSUS EUR 12.2 MILLION YEAR AGO. 

Company Quote

59.1
0.9 +1.55%
18 Oct 2019